Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Single Cell RNA-Seq Characterization of an Adaptive Population of NK Cells after Primary CMV Infection in Rhesus Macaques

Stefan Cordes, Ryland D Mortlock, Lauren Truitt, Di Yang, Diego A Espinoza, Xing Fan, Daniel Ram, Matilda Mostrom, Dollnovan Tran, Lesli Sprehe, R. Keith Reeves, Robert E. Donahue, Michael Kelly, Jinguo Chen, So Gun Hong, Amitinder Kaur, Chuanfeng Wu, Cynthia E. Dunbar

Blood (2021) 138 (Supplement 1): 193.

https://doi.org/10.1182/blood-2021-153667

Published: 2021

Journal Articles

Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-142633

Published: 2020

Journal Articles

Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T Resistance

Katherine Elizabeth Masih, BS, Rebecca Gardner, MD, Berkley Gryder, PhD, Abdelmaksoud Abdallah, BS, Justin Lack, PhD, Benjamin Stanton, PhD, Ashley Wilson, PhD, Sivasish Sindiri, MS, Young Song, PhD, Zachary Rae, BS, Michael Kelly, PhD, Wang Chaoyu, MS, Xinyu Wen, MS, Adam Cheuk, PhD, Jun Wei, PhD, Michael C. Jensen, MD, Javed Khan, MD, Rimas Orentas, PhD

Blood (2019) 134 (Supplement_1): 2744.

https://doi.org/10.1182/blood-2019-130796

Published: 2019

Journal Articles

Single Cell RNA-Sequencing to Uncover Cell Type-Specific Gene Expression Changes during Inv(16) Leukemia Initiation

Jamie Diemer, PhD, Michael Kelly, PhD, Erika Mijin Kwon, PhD, Tao Zhen, PhD, Guadalupe Lopez, Paul P Liu, MD PhD

Blood (2018) 132 (Supplement 1): 1326.

https://doi.org/10.1182/blood-2018-99-111958

Published: 2018

Journal Articles

Haploidentical Hematopoietic Cell Transplantation Followed By Donor Natural Killer Cell Infusion and Sirolimus Maintenance Can Successfully Treat Patients with High-Risk Ewing Sarcoma

Monica Thakar, MD, Meghen Browning, MD, Parameswaran Hari, MD MRCP, MS, John Charlson, MD, Amy Newman, PhD, Brent R. Logan, PhD, Nathan Schloemer, MD, Michael Kelly, MD PhD, Bryon Johnson, PhD, Subramaniam Malarkannan, PhD, Carolyn A. Keever-Taylor, DPhil

Blood (2017) 130 (Supplement 1): 4525.

https://doi.org/10.1182/blood.V130.Suppl_1.4525.4525

Published: 2017

Journal Articles

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Lynda M. Vrooman, MD, Ivan I. Kirov, MD, Zoann E. Dreyer, MD, Michael Kelly, MD, PhD, Nobuko Hijiya, MD, Patrick Brown, MD, Richard A. Drachtman, MD, Yoav H Messinger, MD, A. Kim Ritchey, MD, Gregory A. Hale, MD, Kelly Maloney, MD, Paul V. Plourde, MD, Lewis B. Silverman, MD

Blood (2013) 122 (21): 3904.

https://doi.org/10.1182/blood.V122.21.3904.3904

Published: 2013

Journal Articles

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Philip L. McCarthy, MD, Kouros Owzar, PhD, Kenneth C. Anderson, Craig C. Hofmeister, MD, David Duane Hurd, MD, Hani Hassoun, MD, Sergio Giralt, MD, Edward A. Stadtmauer, MD, Paul G Richardson, MD, Daniel J. Weisdorf, MD, Ravi Vij, MBBS, MD, Jan S Moreb, MD, Natalie Scott Callander, MD, Koen Van Besien, MD, Teresa Gentile, MD, PhD, Luis Isola, MD, Richard T Maziarz, MD, Don A. Gabriel, MD, PhD, Asad Bashey, MD, PhD, Heather Landau, MD, Thomas Martin, MD, Muzaffar H. Qazilbash, MD, Denise Levitan, MD, Brian McClune, MD, Vera Hars, MS, John Postiglione, BA, Chen Jiang, PhD, Elizabeth Bennett, BS, Susan S Barry, BA, Linda Bressler, PharmD, Michael Kelly, MA, Michele Sexton, MS, Cara Rosenbaum, MD, Hari Parameswaran, MD, MS, Marcelo C Pasquini, MD, MS, Mary M. Horowitz, MD, MS, Thomas C. Shea, MD, Steven M Devine, MD, Charles Linker, MD

Blood (2010) 116 (21): 37.

https://doi.org/10.1182/blood.V116.21.37.37

Published: 2010

Journal Articles

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102).

Wendy Stock, MD, Ben Sanford, M.A., Gerard Lozanski, M.D., Ravi Vij, MD, John C. Byrd, Bayard L. Powell, MD, Meir Wetzler, MD, Dorie Sher, B.S., Colin Edwards, Ph.D., Michael Kelly, B.S., Sue Richards, Ph.D, Crystal Sung, PhD, Greg Malnassy, B.S., Eva Hoke, BA, Clara D. Bloomfield, MD, Richard A. Larson, MD

Blood (2009) 114 (22): 838.

https://doi.org/10.1182/blood.V114.22.838.838

Published: 2009

Journal Articles

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events.

Philip L. McCarthy, MD, Kouros Owzar, PhD, Edward A. Stadtmauer, MD, Sergio Giralt, MD, David D Hurd, MD, Hani Hassoun, MD, Craig Hofmeister, MD, Paul Richardson, M.D., Ph.D., Daniel J. Weisdorf, Marcelo C. Pasquini, MD, Vera Hars, PhD, Michael Kelly, B.S., John Postiglione, Susan Sutherland, Kenneth C. Anderson, MD, Charles Linker, MD

Blood (2009) 114 (22): 3416.

https://doi.org/10.1182/blood.V114.22.3416.3416

Published: 2009

Journal Articles

Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.

Thomas C. Shea, MD, Jeffrey Johnston, MA, William Walsh, MD, Sherif Farag, MD, PhD, John McCarty, MD, Asad Bashey, MD, PhD, Luis Isola, MD, Marc Stewart, MD, Michael Kelly, MA, Kouros Owzar, PhD, Charles Linker, MD

Blood (2007) 110 (11): 486.

https://doi.org/10.1182/blood.V110.11.486.486

Published: 2007

Journal Articles

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

Lloyd E. Damon, MD, Jeff Johnson, Donna Niedzwiecki, Bruce D. Cheson, MD, David Duane Hurd, MD, Nancy L. Bartlett, MD, John C. Byrd, Michael Kelly, Charles Linker, MD, George P. Canellos, MD

Blood (2006) 108 (11): 2737.

https://doi.org/10.1182/blood.V108.11.2737.2737

Published: 2006

Journal Articles

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Lloyd Damon, Donna Niedzwiecki, Jeff Johnson, Bruce Cheson, David Hurd, Nancy Barlett, Michael Kelly, Charles Linker, George Canellos

Blood (2004) 104 (11): 895.

https://doi.org/10.1182/blood.V104.11.895.895

Published: 2004

Journal Articles

Third-generation, self-inactivating gp91 phox lentivector corrects the oxidase defect in NOD/SCID mouse–repopulating peripheral blood–mobilized CD34 + cells from patients with X-linked chronic granulomatous disease

Joachim Roesler, Sebastian Brenner, Anatoly A. Bukovsky, Narda Whiting-Theobald, Thomas Dull, Michael Kelly, Curt I. Civin, Harry L. Malech

Blood (2002) 100 (13): 4381–4390.

https://doi.org/10.1182/blood-2001-12-0165

Published: 2002

NARROW

Single Cell RNA-Seq Characterization of an Adaptive Population of NK Cells after Primary CMV Infection in Rhesus Macaques

Integration and Iteration: Using Advanced, High-Content Imaging and Single-Cell Gene Expression Analysis to Uncover Unique Aspects of Follicular Lymphoma Biology

Detailed Multi-Method Analysis of Bone Marrow from Pediatric Pre-B-ALL Patients Prior to CD19-CAR-T Therapy Subsequently Evidencing Overt CAR-T Resistance

Single Cell RNA-Sequencing to Uncover Cell Type-Specific Gene Expression Changes during Inv(16) Leukemia Initiation

Haploidentical Hematopoietic Cell Transplantation Followed By Donor Natural Killer Cell Infusion and Sirolimus Maintenance Can Successfully Treat Patients with High-Risk Ewing Sarcoma

Preliminary Results Of a Pharmacokinetic Study Of Intravenous Asparaginase Erwinia Chrysanthemi Following Allergy To E Coli -Derived Asparaginase In Children, Adolescents, and Young Adults With Acute Lymphoblastic Leukemia Or Lymphoblastic Lymphoma

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Alemtuzumab can be Incorporated Into Front-Line Therapy of Adult Acute Lymphoblastic Leukemia (ALL): Final Phase I Results of a Cancer and Leukemia Group B Study (CALGB 10102).

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events.

Reduced Intensity Allogeneic Transplantation Provides High Disease-Free and Overall Survival in Patients (Pts) with Advanced Indolent NHL and CLL: CALGB 109901.

Immuno-Chemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909.

Intense Immunochemotherapy (IC) and Autologous Stem Cell Transplant (ASCT) for Untreated Patients (pts) with Mantle Cell Lymphoma (MCL): CALGB 59909. A Preliminary Report.

Third-generation, self-inactivating gp91 phox lentivector corrects the oxidase defect in NOD/SCID mouse–repopulating peripheral blood–mobilized CD34 + cells from patients with X-linked chronic granulomatous disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only